SBM:CA Sirona Biochem Corp

CAD 0.07 0.01 16.666667
Icon

Sirona Biochem Corp (SBM:CA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | TSV
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.07000000000000001

+0.01 (+16.67)%

CAD 0.02B

0.03M

N/A

N/A

Icon

SBM:CA

Sirona Biochem Corp (CAD)
COMMON STOCK | TSV
CAD 0.07
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.02B

N/A

CAD 0.07

Sirona Biochem Corp (SBM:CA) Stock Forecast

N/A

Based on the Sirona Biochem Corp stock forecast from 0 analysts, the average analyst target price for Sirona Biochem Corp is not available over the next 12 months. Sirona Biochem Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Sirona Biochem Corp is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Sirona Biochem Corp’s stock price was CAD 0.07000000000000001. Sirona Biochem Corp’s stock price has changed by +7.69% over the past week, -6.67% over the past month and -57.58% over the last year.

No recent analyst target price found for Sirona Biochem Corp
No recent average analyst rating found for Sirona Biochem Corp

Company Overview Sirona Biochem Corp

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-a...Read More

595 Burrard Street, Vancouver, BC, Canada, V7X 1L4

0

October

CAD

Canada

Adjusted Closing Price for Sirona Biochem Corp (SBM:CA)

Loading...

Unadjusted Closing Price for Sirona Biochem Corp (SBM:CA)

Loading...

Share Trading Volume for Sirona Biochem Corp Shares

Loading...

Compare Performance of Sirona Biochem Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SBM:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Sirona Biochem Corp (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NGEN:CA
NervGen Pharma Corp -0.07 (-3.35%) CAD0.16B N/A -6.97

ETFs Containing SBM:CA

Symbol Name SBM:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Sirona Biochem Corp (SBM:CA) Stock

Stock Target Advisor's fundamental analysis for Sirona Biochem Corp's stock is Bearish.

Unfortunately we do not have enough data on SBM:CA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on SBM:CA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on SBM:CA's stock to indicate if its overvalued.

The last closing price of SBM:CA's stock was CAD 0.07.

The most recent market capitalization for SBM:CA is CAD 0.02B.

Unfortunately we do not have enough analyst data on SBM:CA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Sirona Biochem Corp's stock.

As per our most recent records Sirona Biochem Corp has 0 Employees.

Sirona Biochem Corp's registered address is 595 Burrard Street, Vancouver, BC, Canada, V7X 1L4. You can get more information about it from Sirona Biochem Corp's website at https://www.sironabiochem.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...